Full-Time

Principal Scientist

Molecular Biology Analytics, Analytical Development

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Senior, Expert

Somerset County, NJ, USA

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • PhD degree in cell/molecular biology, virology, immunology or other related science.
  • 7-15 years’ experience in method development of gene-modified products.
  • Expertise in analytical method development and validation is required.
  • Authored source documents and / or sections of regulatory submissions is preferred.
  • Strong written and verbal communication skills are essential.
  • Expertise in mentoring and scientific leadership.
  • Understanding of viral vector technology, design & manufacturing for gene or cell therapies is preferred.
  • Detail-oriented with expertise in problem solving and solid decision-making abilities.
  • Excellent presentation skills and scientific/technical writing skills.
  • Ability to operate independently and lead a team environment.
  • Language(s): English and Mandarin is desired.
Responsibilities
  • Drive method development to meet established timeline while maintaining the highest quality and data integrity standards. Lead efforts in tech transfer or assays from R&D teams to advance assays toward GMP operations and identify critical parameters within assays for qualification activities.
  • Direct method development forward through collaborative involvement or through mentoring of direct reports.
  • Develop and optimize molecular biology methods for parameters such as: VCN, gene editing proficiency, infectious titer, genomic titer, rapid mycoplasma, surrogate RCL, residual DNA, etc.
  • Proficient in ddPCR/dPCR technologies with experiences in evaluating gene edited products. Direct experience with establishing libraries for sequencing and / or analysis of sequencing data for gene edited products is a plus.
  • Ability to design, execute and / or direct the development and qualification of release, characterization, and stability assays for testing of a clinical trial (first-in-human/new IND) and in support of product and process development. May also execute qualified methods in QC environment.
  • Establish and author SOPs/procedures for methods developed. Author and / or review technical reports, sections of regulatory filings (e.g., IND) and external scientific publications.
  • Maintain accurate and updated lab notebooks.
  • Manage equipment and records for maintenance, calibration and operation. Contribute to maintenance of laboratory inventories.
  • Analyze data for trends and recommendations for scientific staff. Present analyzed data within and across departmental meetings.
  • Act as Subject Matter Expert (SME) in technology transfers of product-specific methods to QC, to external partners and between sites. Contribute to method qualification activities.
  • Provide analytical support as SME for manufacturing and QC root cause investigations for OOS/OOE.
  • Procure and qualify required materials to perform experiments or testing.
  • May work directly with external vendors to resolve reagent or equipment issues.
  • May participate in audits of 3rd party vendors as SME.
  • Work collaboratively with member(s) of Analytical Development team to establish the analytical control strategy of the established methods.

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
  • New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
  • Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

What critics are saying

  • Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
  • Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
  • Financial strain from new R&D facility could affect operational focus if advancements lag.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options